HWAY Related Analyst Ratings
-
William Blair Upgrades Healthways (HWAY) to Outperform
-
Citi Starts Healthways (HWAY) at Sell
-
Noble Financial Downgrades Healthways (HWAY) to Hold
-
Noble Financial Upgrades Healthways (HWAY) to Buy, Sets $12 Price TArget
-
Dougherty & Co Upgrades Healthways (HWAY) to Buy
-
Noble Financial Upgrades Healthways (HWAY) to Hold
-
Stifel Nicolaus Upgrades Healthways (HWAY) to Buy
-
Dougherty & Co Downgrades Healthways (HWAY) to Neutral, Cuts Price Target on Cigna (CI) News
-
UPDATE - Barclays Downgraded Healthways (HWAY) to Underweight; Obvious Earnings Pressure as Larger Risks Become More Evident
-
Noble Financial Downgrades Healthways (HWAY) to Sell
-
Barclays Downgrades Healthways (HWAY) to Underweight
-
Piper Jaffray Downgrades Healthways (HWAY) to Neutral
-
BB&T Capital Downgrades Healthways (HWAY) to Underweight
-
William Blair Downgrades Healthways (HWAY) to Market Perform
-
Piper Jaffray Upgrades Healthways (HWAY) to Overweight
-
JMP Securities Upgrades Healthways (HWAY) to Market Perform
-
Dougherty & Co. Raises Price Target on Healthways (HWAY), Now Is a Great Buying Opportunity
-
Barclays maintains an 'Equalweight' on Healthways (HWAY); 2Q In Line with Our Estimates, With Revenue Outlook Gaining Clarity
-
JMP Securities Downgrades Healthways (HWAY) to Market Underperform
-
Standpoint Research Downgrades Healthways (HWAY) to Hold; Valuation Call
-
FBR Capital Maintains an 'Outperform' on Healthways (HWAY); Takeaways from Management Meetings
-
FBR Capital Reiterates an 'Outperform' on Healthways (HWAY); Ability There, Now It's Time for Delivery
-
FBR Capital Maintains an 'Outperform' on Healthways (HWAY); Rough 1Q11 Shouldn’t Scare You Away
-
FBR Capital on Healthcare Services 1Q11 Earnings Preview
-
Barclays Maintains an 'Equalweight' on Healthways (HWAY); 2011 Facing Headwinds, But More Visibility and Foundation for 2012
-
FBR Capital Maintains an 'Outperform' on Healthways (HWAY); Near-Term Investment Mutes 2011 Outlook
-
FBR Capital Maintains an 'Outperform' on Healthways (HWAY); Large Contracts Signal Higher Costs in 2011
-
Madison Williams Downgrades Healthways (HWAY) to Sell
-
FBR Capital: Healthcare Services 2011 Outlook
-
Barclays maintain an 'Equalweight' rating on Healthways (HWAY); Medicare Pilot Follow Up: Updating 2010 Estimates for One-Time Favorable Items
-
FBR Capital Maintains an 'Outperform' Rating on Healthways (HWAY); The Day Has Come
-
FBR Capital Maintains an 'Outperform' Rating on Healthways (HWAY); 3Q10 Embracing the Change, but Feeling the Near-Term Pain
-
Hilliard Lyons Downgrades Healthways (HWAY) to Neutral
-
BB&T Capital Downgrades Healthways (HWAY) to Hold
-
Madison Williams Downgrade Bringing Healthways (HWAY) Shares Down Today
-
FBR Capital Launching Coverage of Pharmacy Benefit Management Services: Trends Favor the Prepared
-
Noble Financial Upgrades Healthways (HWAY) to Buy
-
Madison Williams Downgrades Healthways (HWAY) to Neutral
-
Madison Williams Downgrades Healthways (HWAY) to Accumulate
-
Stifel Nicolaus Downgrades Healthways (HWAY) to Hold
-
Jefferies & Co Upgrades Healthways (HWAY) to Buy
-
Piper Jaffray Upgrades Healthways (HWAY) to Neutral; Strong Execution in Tough Environment
-
William Blair Upgrades Healthways (HWAY) to Outperform
-
BB&T Capital Upgrades Healthways (HWAY) to Buy
-
Goldman Sachs Downgrades Healthways Inc. (HWAY) to Sell
-
BB&T Capital Downgrades Healthways (HWAY) to Hold
-
Piper Jaffray Downgrades Healthways (HWAY) to Sell
-
Matrix Lighthouse Rating Changes 1/14
-
Jefferies Upgrades Healthways (HWAY) to Hold
-
Matrix Lighthouse Rating Changes 11/06
Back to HWAY Stock Lookup
